Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS
Clin Transl Med
.
2022 May;12(5):e838.
doi: 10.1002/ctm2.838.
Authors
María C García-Hidalgo
1
,
Jessica González
1
2
,
Iván D Benítez
1
2
,
Paola Carmona
1
,
Sally Santisteve
1
,
Anna Moncusí-Moix
1
2
,
Clara Gort-Paniello
1
2
,
Fátima Rodríguez-Jara
1
2
,
Marta Molinero
1
,
Manel Perez-Pons
1
2
,
Gerard Torres
1
2
,
Jesús Caballero
3
,
Carme Barberà
4
,
Ana P Tedim
5
6
,
Raquel Almansa
2
5
6
,
Adrián Ceccato
2
,
Laia Fernández-Barat
2
7
,
Ricard Ferrer
2
8
,
Dario Garcia-Gasulla
9
,
Rosario Menéndez
2
10
,
Ana Motos
2
7
,
Oscar Peñuelas
2
11
,
Jordi Riera
2
8
,
Jesús F Bermejo-Martin
2
5
6
,
Antoni Torres
2
7
,
Ferran Barbé
1
2
,
David de Gonzalo-Calvo
1
2
;
CIBERESUCICOVID Project (COV20/00110, ISCIII)
Affiliations
1
Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.
2
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
3
Intensive Care Department, University Hospital Arnau de Vilanova, IRBLleida, Lleida, Spain.
4
Intensive Care Department, University Hospital Santa María, IRBLleida, Lleida, Spain.
5
Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.
6
Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
7
Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
8
Intensive Care Department, Vall d'Hebron Hospital Universitari, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Spain.
9
Barcelona Supercomputing Center (BSC), Barcelona, Spain.
10
Pulmonology Service, University and Polytechnic Hospital La Fe, Valencia, Spain.
11
Hospital Universitario de Getafe, Madrid, Spain.
PMID:
35538880
PMCID:
PMC9091985
DOI:
10.1002/ctm2.838
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Lung
Proteomics
Respiratory Distress Syndrome*
SARS-CoV-2